Pliant Therapeutics (PLRX) Assets Average (2020 - 2026)

Pliant Therapeutics (PLRX) has 7 years of Assets Average data on file, last reported at $213.9 million in Q1 2026.

• Assets Average for Q1 2026 came in at $213.9 million, down 42.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.9 million (down 42.32% YoY), and the FY2025 annual result was $311.1 million, down 31.56% from the prior year.
• Assets Average retreated to $213.9 million in Q1 2026 per PLRX's latest filing, from $250.9 million in the prior quarter.
• Over five years, Assets Average peaked at $586.4 million in Q2 2023 and troughed at $190.8 million in Q2 2022.
• A 5-year average of $384.8 million and a median of $370.9 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2023 and 2026: Assets Average soared 207.3% in 2023, then sank 42.32% in 2026.
• A 5-year view of Assets Average shows it stood at $363.9 million in 2022, then surged by 44.63% to $526.3 million in 2023, then decreased by 19.95% to $421.3 million in 2024, then slumped by 40.44% to $250.9 million in 2025, then slipped by 14.75% to $213.9 million in 2026.
• Business Quant data shows PLRX's Assets Average at $213.9 million in Q1 2026, $250.9 million in Q4 2025, and $288.2 million in Q3 2025.